EVERYTHING ABOUT API IN PHARMACEUTICAL MANUFACTURING

“The present scenario has exposed some structural weaknesses within the EU’s medicines source chain along with a significant dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides reported. She advised that supply chain concerns be tackled within an EU pharmaceutical technique expected to be introduce